Detalles de la búsqueda
1.
BNT162b2 Effectiveness Against Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2 in Adolescents Aged 12-17 Years, by Dosing Interval and Duration.
J Infect Dis
; 227(9): 1073-1083, 2023 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36645782
2.
Vaccine Effectiveness Against 12-Month Incident and Persistent Anal Human Papillomavirus Infection Among Gay, Bisexual, and Other Men Who Have Sex With Men.
J Infect Dis
; 228(1): 89-100, 2023 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36655513
3.
Self-reported Human Papillomavirus Vaccination and Vaccine Effectiveness Among Men Who Have Sex with Men: A Quantitative Bias Analysis.
Epidemiology
; 34(2): 225-229, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36722804
4.
Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Québec, Canada.
Clin Infect Dis
; 75(1): e805-e813, 2022 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34460902
5.
Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada.
Clin Infect Dis
; 75(11): 1980-1992, 2022 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35438175
6.
Time trends in social contacts of individuals according to comorbidity and vaccination status, before and during the COVID-19 pandemic.
BMC Med
; 20(1): 199, 2022 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35606803
7.
Time trends in social contacts before and during the COVID-19 pandemic: the CONNECT study.
BMC Public Health
; 22(1): 1032, 2022 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35606703
8.
Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical Trial.
Clin Infect Dis
; 71(4): 1022-1029, 2020 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31617568
9.
Effectiveness and cost-effectiveness of vaccination against herpes zoster in Canada: a modelling study.
CMAJ
; 191(34): E932-E939, 2019 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31451524
10.
Promoting vaccination in the province of Québec: the PromoVaQ randomized controlled trial protocol.
BMC Public Health
; 19(1): 160, 2019 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30727991
11.
Promoting vaccination in maternity wards â motivational interview technique reduces hesitancy and enhances intention to vaccinate, results from a multicentre non-controlled pre- and post-intervention RCT-nested study, Quebec, March 2014 to February 2015.
Euro Surveill
; 24(36)2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31507265
12.
Impact of vaccine delays at the 2, 4, 6 and 12 month visits on incomplete vaccination status by 24 months of age in Quebec, Canada.
BMC Public Health
; 18(1): 1364, 2018 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30537969
13.
Herpes Zoster Burden in Canadian Provinces: A Narrative Review and Comparison with Quebec Provincial Data.
Can J Infect Dis Med Microbiol
; 2018: 3285327, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30420904
14.
"Nature Does Things Well, Why Should We Interfere?": Vaccine Hesitancy Among Mothers.
Qual Health Res
; 26(3): 411-25, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25711847
15.
Impact of interventions to improve HPV vaccination acceptance and uptake in school-based programs: Findings of a pilot project in Quebec.
Vaccine
; 42(18): 3768-3773, 2024 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38714451
16.
Effectiveness of BNT162b2 Vaccine Against Omicron-SARS-CoV-2 Subvariants in Children 5-11 Years of Age in Quebec, Canada, January 2022 to January 2023.
Pediatr Infect Dis J
; 43(1): 32-39, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37922479
17.
School-based vaccination program against HPV and Hepatitis B: A longitudinal analysis of vaccine coverage between 2015 and 2021 in Quebec.
Vaccine
; 42(1): 17-23, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38044245
18.
Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.
JAMA
; 309(17): 1793-802, 2013 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23632723
19.
[Knowledge and attitudes toward vaccination among midwives in Quebec]. / Attitudes et croyances des sages-femmes québécoises sur la vaccination.
Sante Publique
; 25(1): 35-43, 2013.
Artículo
en Francés
| MEDLINE | ID: mdl-23705333
20.
"The problem is not lack of information": A qualitative study of parents and school nurses' perceptions of barriers and potential solutions for HPV vaccination in schools.
Vaccine
; 41(45): 6654-6660, 2023 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37777452